#Pharma AstraZeneca buys heart drug firm Omthera for up to US$443mil http://t.co/dwTIR03Qb6 @ghabault
May 28, 2013
Publicité
/http%3A%2F%2Fbiz.thestar.com.my%2Fimages%2Fbudget2013tile.jpg)
AstraZeneca buys heart drug firm Omthera for up to US$443mil
LONDON: AstraZeneca has agreed to buy Omthera Pharmaceuticals for up to $443 million to build up its cardiovascular drug business, which Britain's second biggest drugmaker has previously identified as a priority area. AstraZeneca said on Tuesday it had entered into a definitive agreement to buy Omthera for $12.70 per share, or approximately $323 million, a premium of 88 percent on Omthera's closing price on Friday.